Neuroproteomics: A biochemical means to discriminate the extent and modality of brain injury

Journal of Neurotrauma

Volumn 27, Issue 10, 2010, Pages 1837-1852

  Ottens, Andrew K ^a   Bustamante, Liliana ^b   Golden, Erin C ^b   Yao, Changping ^c   Hayes, Ronald L ^d   Wang, Kevin K W ^b,d   Tortella, Frank C ^c   Dave, Jitendra R ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d BANYAN BIOMARKERS INC   (United States)

Author keywords

controlled cortical impact; ischemia; middle cerebral artery occlusion; proteomics; traumatic brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHAPERONE; MALIC ACID; MICROTUBULE ASSOCIATED PROTEIN 2; PENTOSE PHOSPHATE; TRANSGELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BRAIN CONTUSION; BRAIN ISCHEMIA; BRAIN METABOLISM; CELL SURVIVAL; CONTROLLED STUDY; CYTOARCHITECTURE; GEL ELECTROPHORESIS; IMMUNOBLOTTING; ION EXCHANGE CHROMATOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEOCORTEX; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN PROCESSING; PROTEOMICS; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SYNAPSE; TANDEM MASS SPECTROMETRY; TRAUMATIC BRAIN INJURY; UNINDEXED SEQUENCE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN INJURIES; BRAIN ISCHEMIA; CHROMATOGRAPHY, ION EXCHANGE; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; MALE; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TANDEM MASS SPECTROMETRY;

EID: 77958180262     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1374     Document Type: Article

References (89)

1. Agoston, D. V., Gyorgy, A., Eidelman, O., and Pollard, H. B. (2009). Proteomic biomarkers for blast neurotrauma: targeting cerebral edema, inflammation, and neuronal death cascades. J. Neurotrauma. 26, 901-911.
2. Angeletti, P. C., Walker, D., and Panganiban, A. T. (2002). Small glutamine-rich protein/viral protein U-binding protein is a novel cochaperone that affects heat shock protein 70 activity. Cell Stress Chaperones 7, 258-268.
3. Baird, A. E. (2006). Blood biologic markers of stroke: improved management, reduced cost? Curr. Atheroscler. Rep. 8, 267-275.
4. Baron, J. C. (2001). Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc. Dis. 11 (Suppl. 1), 2-8.
5. Berger, R. P., Beers, S. R., Richichi, R., Wiesman, D., and Adelson, P. D. (2007). Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J. Neurotrauma 24, 1793-1801.
6. Berger, R. P., Ta'asan, S., Rand, A., Lokshin, A., and Kochanek, P. (2009). Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury. Pediatr. Res. 65, 97-102.
7. Berger, R., Pierce, M., Wisniewski, S., Adelson, P. D., Clark, R. S. B., Ruppel, R., and Kochanek, P. (2002). Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109, E31-E31.
8. Britton, P., May, X. C., Laskosky, M. S., and Tortella, F. C. (1997). Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. Life Sci. 60, 1729-1740.
9. Buttner, T., Weyers, S., Postert, T., Sprengelmeyer, R., and Kuhn, W. (1997). S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 28, 1961-1965.
10. Chan, P. H. (2004). Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem. Res. 29, 1943-1949.
11. Chen, A., Liao, W. P., Lu, Q., Wong, W. S., and Wong, P. T. (2007). Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats-a proteomics approach. Neurochem. Int. 50, 1078-1086.
12. Chen, D. M., Xiao, L., Cai, X., Zeng, R., and Zhu, X. Z. (2006). Involvement of multitargets in paeoniflorin-induced preconditioning. J. Pharmacol. Exp. Ther. 319, 165-180.
13. Chen, M., Clark, R. S., Kochanek, P. M., Chen, J., Schiding, J. K., Stetler, R. A., Simon, R. P., and Graham, S. H. (1998). 72-kDa heat shock protein and mRNA expression after controlled cortical impact injury with hypoxemia in rats. J. Neurotrauma 15, 171-181.
14. Cid, C., Garcia-Bonilla, L., Camafeita, E., Burda, J., Salinas, M., and Alcazar, A. (2007). Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance. Proteomics 7, 3207-3218.
15. Cunningham, R. T., Watt, M., Winder, J., McKinstry, S., Lawson, J. T., Johnston, C. F., Hawkins, S. A., and Buchanan, K. D. (1996). Serum neurone-specific enolase as an indicator of stroke volume. Eur. J. Clin. Invest. 26, 298-303.
16. Cunningham, R. T., Young, I. S., Winder, J., O'Kane, M. J., McKinstry, S., Johnston, C. F., Dolan, O. M., Hawkins, S. A., and Buchanan, K. D. (1991). Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur. J. Clin. Invest. 21, 497-500.
17. Daniel, S., Bradley, G., Longshaw, V. M., Soti, C., Csermely, P., and Blatch, G. L. (2008). Nuclear translocation of the phosphoprotein Hop (Hsp70/Hsp90 organizing protein) occurs under heat shock, and its proposed nuclear localization signal is involved in Hsp90 binding. Biochim. Biophys. Acta. 1783, 1003-1014.
18. Dash, P. K., Kobori, N., and Moore, A. N. (2004). A molecular description of brain trauma pathophysiology using microarray technology: an overview. Neurochem. Res. 29, 1275-1286.
19. Dash, P. K., Zhao, J., Hergenroeder, G., and Moore, A. N. (2010). Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 7, 100-114.
20. Dauberschmidt, R., Zinsmeyer, J., Mrochen, H., and Meyer, M. (1991). Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol. Chem. Neuropathol. 14, 237-245.
21. Depaz, I. M., and Wilce, P. A. (2006). The novel cytoskeleton-associated protein neuronal protein 22: elevated expression in the developing rat brain. Brain Res. 1081, 59-64.
22. Dhodda, V., Sailor, K., Bowen, K., and Vemuganti, R. (2004). Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J. Neurochem. 89, 73-89.
23. Dubaquie, Y., Looser, R., and Rospert, S. (1997). Significance of chaperonin 10-mediated inhibition of ATP hydrolysis by chaperonin 60. Proc. Natl. Acad. Sci. USA 94, 9011-9016.
24. Ekegren, T., Hanrieder, J., and Bergquist, J. (2008). Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research. J/Mass Spectrom. 43, 559-571.
25. Focking, M., Besselmann, M., and Trapp, T. (2006). Proteomics of experimental stroke in mice. Acta Neurobiol. Exp. (Wars.) 66, 273-278.
26. Gao, W., Chadha, M., Berger, R., Omenn, G., Allen, D., Pisano, M., Adelson, P. D., Clark, R. S. B., Jenkins, L., and Kochanek, P. (2007). A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury. J. Neurotrauma 24, 43-53.
27. Giffard, R. G., Xu, L., Zhao, H., Carrico, W., Ouyang, Y., Qiao, Y., Sapolsky, R., Steinberg, G., Hu, B., and Yenari, M. A. (2004). Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J. Exp. Biol. 207, 3213-3220.
28. Hanrieder, J., Wetterhall, M., Enblad, P., Hillered, L., and Bergquist, J. (2009). Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J. Neurosci. Meth. 177, 469-478.
29. Haqqani, A., Hutchison, J., Ward, R., and Stanimirovic, D. (2007). Biomarkers and diagnosis protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. J. Neurotrauma 24, 54-74.
30. Hergenroeder, G., Redell, J. B., Moore, A. N., Dubinsky, W. P., Funk, R. T., Crommett, J., Clifton, G. L., Levine, R., Valadka, A., and Dash, P. K. (2008a). Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J. Neurotrauma 25, 79-93.
31. Hergenroeder, G. W., Moore, A. N., McCoy, J. P. Jr, Samsel, L., Ward, N. H. 3rd, Clifton, G. L., and Dash, P. K. (2010). Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J. Neuroinflammation 7, 19.
32. Hergenroeder, G. W., Redell, J. B., Moore, A. N., and Dash, P. K. (2008b). Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol. Diagn. Ther. 12, 345-358.
33. Ito, M., Depaz, I., Wilce, P., Suzuki, T., Niwa, S., and Matsumoto, I. (2005). Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neurosci. Lett. 378, 125-130.
34. Jenkins, L. W., Peters, G. W., Dixon, C. E., Zhang, X., Clark, R. S. B., Skinner, J. C., Marion, D. W., Adelson, P. D., and Kochanek, P. M. (2002). Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. J. Neurotrauma 19, 715-740.
35. Junker, H., Suofu, Y., Venz, S., Sascau, M., Herndon, J. G., Kessler, C., Walther, R., and Popa-Wagner, A. (2007). Proteomic identification of an upregulated isoform of annexin A3 in the rat brain following reversible cerebral ischemia. Glia 55, 1630-1637.
36. Kang, C. B., Hong, Y., Dhe-Paganon, S., and Yoon, H. S. (2008). FKBP family proteins: immunophilins with versatile biological functions. Neurosignals 16, 318-325.
37. Kent, D. M., Ruthazer, R., and Selker, H. P. (2003). Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke 34, 464-467.
38. Khan, M., Im, Y. B., Shunmugavel, A., Gilg, A. G., Dhindsa, R. K., Singh, A. K., and Singh, I. (2009). Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J. Neuroinflammation 6, 32.
39. Kleindienst, A., Hesse, F., Bullock, M. R., and Buchfelder, M. (2007). The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog. Brain Res. 161, 317-325.
40. Kleindienst, A., and Ross Bullock, M. (2006). A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J. Neurotrauma 23, 1185-1200.
41. Kleindienst, A., Tolias, C. M., Corwin, F. D., Muller, C., Marmarou, A., Fatouros, P., and Bullock, M. R. (2005). Assessment of cerebral S100B levels by proton magnetic resonance spectroscopy after lateral fluid-percussion injury in the rat. J. Neurosurg. 102, 1115-1121.
42. Kobeissy, F. H., Ottens, A. K., Zhang, Z., Liu, M. C., Denslow, N. D., Dave, J. R., Tortella, F. C., Hayes, R. L., and Wang, K. K. (2006). Novel differential neuroproteomics analysis of traumatic brain injury in rats. Mol. Cell Proteomics 5, 1887-1898.
43. Kochanek, A., Kline, A., Gao, W., Chadha, M., Lai, Y., Clark, R. S. B., Dixon, C. E., and Jenkins, L. (2006). Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact. Dev. Neurosci. 28, 410-419.
44. Kochanek, P., Berger, R., Bayir, H., Wagner, A., Jenkins, L., and Clark, R. S. B. (2008). Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr. Opin. Crit. Care. 14, 135-141.
45. Koh, P. O. (2009). Proteomic analysis of focal cerebral ischemic injury in male rats. J. Vet. Med. Sci. 72, 181-185.
46. Kukacka, J., Vajtr, D., Huska, D., Prusa, R., Houstava, L., Samal, F., Diopan, V., Kotaska, K., and Kizek, R. (2006). Blood metallothionein, neuron specific enolase, and protein S100B in patients with traumatic brain injury. Neuro. Endocrinol. Lett. 27 (Suppl. 2), 116-120.
47. Laskowitz, D. T., Kasner, S. E., Saver, J., Remmel, K. S., Jauch, E. C., and BRAIN Study Group. (2009). Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 40, 77-85.
48. Lee, J. E., Yenari, M. A., Sun, G. H., Xu, L., Emond, M. R., Cheng, D., Steinberg, G. K., and Giffard, R. G. (2001). Differential neuroprotection from human heat shock protein 70 overexpression in in vitro and in vivo models of ischemia and ischemia-like conditions. Exp. Neurol. 170, 129-139.
49. Liu, M. C., Akle, V., Zheng, W., Dave, J. R., Tortella, F. C., Hayes, R. L., and Wang, K. K. (2006). Comparing calpain-and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem. J. 394, 715-725.
50. Lynch, J. R., Blessing, R., White, W. D., Grocott, H. P., Newman, M. F., and Laskowitz, D. T. (2004). Novel diagnostic test for acute stroke. Stroke 35, 57-63.
51. Macleod, M. R., O'Collins, T., Horky, L. L., Howells, D. W., and Donnan, G. A. (2005). Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J. Cereb. Blood Flow Metab. 25, 713-721.
52. Martens, P., Raabe, A., and Johnsson, P. (1998). Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 29, 2363-2366.
53. Minambres, E., Cemborain, A., Sanchez-Velasco, P., Gandarillas, M., Diaz-Reganon, G., Sanchez-Gonzalez, U., and Leyva-Cobian, F. (2003). Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit. Care Med. 31, 933-938.
54. Minger, S. L., Geddes, J. W., Holtz, M. L., Craddock, S. D., Whiteheart, S. W., Siman, R. G., and Pettigrew, L. C. (1998). Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia. Brain Res. 810, 181-199.
55. Missler, U., Wiesmann, M., Friedrich, C., and Kaps, M. (1997). S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28, 1956-1960.
56. Montaner, J. (2006). Stroke biomarkers: Can they help us to guide stroke thrombolysis? Drug News Perspect. 19, 523-532.
57. Ottens, A. K., Kobeissy, F. H., Fuller, B. F., Liu, M. C., Oli, M. W., Hayes, R. L., and Wang, K. K. (2007). Novel neuroproteomic approaches to studying traumatic brain injury. Prog. Brain Res. 161, 401-418.
58. Ottens, A. K., Kobeissy, F. H., Golden, E. C., Zhang, Z., Haskins, W. E., Chen, S. S., Hayes, R. L., Wang, K. K., and Denslow, N. D. (2006). Neuroproteomics in neurotrauma. Mass Spectrom. Rev. 25, 380-408.
59. Ottens, A. K., Kobeissy, F. H., Wolper, R. A., Haskins, W. E., Hayes, R. L., Denslow, N. D., and Wang, K. K. (2005). A multidimensional differential proteomic platform using dualphase ion-exchange chromatography-polyacrylamide gel electrophoresis/reversed-phase liquid chromatography tandem mass spectrometry. Anal. Chem. 77, 4836-4845.
60. Pak, J. H., Huang, F. L., Li, J., Balschun, D., Reymann, K. G., Chiang, C., Westphal, H., and Huang, K. P. (2000). Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice. Proc. Natl. Acad. Sci. USA 97, 11232-11237.
61. Pettigrew, L. C., Holtz, M. L., Craddock, S. D., Minger, S. L., Hall, N., and Geddes, J. W. (1996). Microtubular proteolysis in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16, 1189-1202.
62. Pike, B. R., Flint, J., Dave, J. R., Lu, X. C., Wang, K. K., Tortella, F. C., and Hayes, R. L. (2004). Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 24, 98-106.
63. Pineda, J. A., Wang, K. K., and Hayes, R. L. (2004). Biomarkers of proteolytic damage following traumatic brain injury. Brain Pathol. 14, 202-209.
64. Pleines, U. E., Morganti-Kossmann, M. C., Rancan, M., Joller, H., Trentz, O., and Kossmann, T. (2001). S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J. Neurotrauma 18, 491-498.
65. Posmantur, R. M., Kampfl, A., Taft, W. C., Bhattacharjee, M., Dixon, C. E., Bao, J., and Hayes, R. L. (1996). Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. J. Neurotrauma 13, 125-137.
66. Prieto, D. A., Ye, X., and Veenstra, T. D. (2008). Proteomic analysis of traumatic brain injury: the search for biomarkers. Expert Rev. Proteomics. 5, 283-291.
67. Rajdev, S., and Sharp, F. R. (2000). Stress proteins as molecular markers of neurotoxicity. Toxicol. Pathol. 28, 105-112.
68. Reynolds, M. A., Kirchick, H. J., Dahlen, J. R., Anderberg, J. M., McPherson, P. H., Nakamura, K. K., Laskowitz, D. T., Valkirs, G. E., and Buechler, K. F. (2003). Early biomarkers of stroke. Clin. Chem. 49, 1733-1739.
69. Roine, R. O., Somer, H., Kaste, M., Viinikka, L., and Karonen, S. L. (1989). Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch. Neurol. 46, 753-756.
70. Schellinger, P. D., Fiebach, J. B., and Hacke, W. (2003). Imagingbased decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34, 575-583.
71. Shibasaki, F., Kondo, E., Akagi, T., and McKeon, F. (1997). Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 386, 728-731.
72. Siman, R., Toraskar, N., Dang, A., McNeil, E., McGarvey, M., Plaum, J., Maloney, E., and Grady, M. S. (2009). A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J. Neurotrauma 26, 1867-1877.
73. Singleton, R. H., Stone, J. R., Okonkwo, D. O., Pellicane, A. J., and Povlishock, J. T. (2001). The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. J. Neurotrauma 18, 607-614.
74. Sullivan, P. G., Rabchevsky, A. G., Waldmeier, P. C., and Springer, J. E. (2005). Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J. Neurosci. Res. 79, 231-239.
75. Sung, J. H., Cho, E. H., Kim, M. O., and Koh, P. O. (2009). Identification of proteins differentially expressed by melatonin treatment in cerebral ischemic injury-a proteomics approach. J. Pineal Res. 46, 300-306.
76. Terada, K., Inao, S., Mizutani, N., Tsukada, H., and Yoshida, J. (2001). Cerebral blood flow, glucose metabolism and tunelpositive cells in the development of ischemia. Cerebrovasc. Dis. 11, 9-19.
77. Tsuchiya, D., Hong, S., Matsumori, Y., Kayama, T., Swanson, R. A., Dillman, W. H., Liu, J., Panter, S. S., and Weinstein, P. R. (2003). Overexpression of rat heat shock protein 70 reduces neuronal injury after transient focal ischemia, transient global ischemia, or kainic acid-induced seizures. Neurosurgery 53, 1179-1187; discussion 1187-1188.
78. Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D., and Fowkes, F. G. (2007a). Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur. Heart J. 28, 354-362.
79. Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D., and Fowkes, F. G. (2007b). Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation 115, 2119-2127.
80. Wang, H. G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shibasaki, F., McKeon, F., Bobo, T., Franke, T. F., and Reed, J. C. (1999). Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284, 339-343.
81. Williams, A. J., Dave, J. R., Phillips, J. B., Lin, Y., McCabe, R. T., and Tortella, F. C. (2000). Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J. Pharmacol. Exp. Ther. 294, 378-386.
82. Wunderlich, M. T., Lins, H., Skalej, M., Wallesch, C. W., and Goertler, M. (2006). Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin. Neurol. Neurosurg. 108, 558-563.
83. Yao, C., Williams, A. J., Lu, X. C., Price, R. A., Cunningham, B. S., Berti, R., Tortella, F. C., and Dave, J. R. (2003). The sodium channel blocker RS100642 reverses down-regulation of the sodium channel alpha-subunit Na (v) 1.1 expression caused by transient ischemic brain injury in rats. Neurotox. Res. 5, 245-253.
84. Yao, C., Williams, A. J., Ottens, A., Lu, X. C., Liu, M. C., Hayes, R. L., Wang, K. K., Tortella, F. C., and Dave, J. R. (2009). P43/pro-EMAP-II: A potential biomarker for discriminating traumatic versus ischemic brain injury. J. Neurotrauma 26, 1295-1305.
85. Yao, C., Williams, A. J., Ottens, A. K., May Lu, X. C., Chen, R., Wang, K. K., Hayes, R. L., Tortella, F. C., and Dave, J. R. (2008). Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballisticlike brain injuries in rats. Brain Inj. 22, 723-732.
86. Yao, H., Nakahara, T., Nakagawa, N., Hashimoto, K., and Kuroki, T. (2009). Regional and temporal changes in proteomic profile after middle cerebral artery occlusion with or without reperfusion in rats. Neurochem. Res. 34, 1999-2007.
87. Zetterberg, H., Ruetschi, U., Portelius, E., Brinkmalm, G., Andreasson, U., Blennow, K., and Brinkmalm, A. (2008). Clinical proteomics in neurodegenerative disorders. Acta Neurol. Scand. 118, 1-11.
88. Zhang, J., Keene, C. D., Pan, C., Montine, K. S., and Montine, T. J. (2008). Proteomics of human neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 67, 923-932.
89. Zhang, Z., Wu, R., Li, P., Liu, F., Zhang, W., Zhang, P., Li, P., and Wang, Y. (2009). Baicalin administration is effective in positive regulation of twenty-four ischemia/reperfusion-related proteins identified by a proteomic study. Neurochem. Int. 54, 488-496.